| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 67321 |
NHS-PEG2-NH-Xanomeline，ADC定制 |
78 |
wyh |
2024-12-19 |
| 67322 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
112 |
h |
2024-12-19 |
| 67323 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
69 |
h |
2024-12-19 |
| 67324 |
cas:2123482-78-8，TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
60 |
zyl |
2024-12-19 |
| 67325 |
GG-Tesirine，ADC定制 |
103 |
wyh |
2024-12-19 |
| 67326 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
143 |
h |
2024-12-19 |
| 67327 |
MC-GGFG-Exatecan，ADC定制 |
115 |
wyh |
2024-12-19 |
| 67328 |
亲和素-AMF-DOTA(Nd) |
87 |
h |
2024-12-19 |
| 67329 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
90 |
h |
2024-12-19 |
| 67330 |
MC-VA-PBD，MC-Val-Ala-PBD，ADC定制 |
168 |
wyh |
2024-12-19 |
| 67331 |
cas:2241685-22-1，DADPS Biotin Alykne |
80 |
zyl |
2024-12-19 |
| 67332 |
MC-vc-PAB-C6-Alpha-Amanitin，ADC定制 |
63 |
wyh |
2024-12-19 |
| 67333 |
MPB-MMAF，ADC定制 |
116 |
wyh |
2024-12-19 |
| 67334 |
DOTA–Bipy–RuII配位共轭物 |
116 |
h |
2024-12-19 |
| 67335 |
cas:1007215-91-9，1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
101 |
zyl |
2024-12-19 |
| 67336 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
73 |
h |
2024-12-19 |
| 67337 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
84 |
h |
2024-12-19 |
| 67338 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
86 |
h |
2024-12-19 |
| 67339 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
73 |
h |
2024-12-19 |
| 67340 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
123 |
h |
2024-12-19 |
| 67341 |
DOTA-c(RGDfK)DOTA偶联环肽 |
83 |
h |
2024-12-19 |
| 67342 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
99 |
h |
2024-12-19 |
| 67343 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
85 |
h |
2024-12-19 |
| 67344 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
144 |
h |
2024-12-19 |
| 67345 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
137 |
h |
2024-12-19 |
| 67346 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
98 |
h |
2024-12-19 |
| 67347 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
74 |
zyl |
2024-12-19 |
| 67348 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
70 |
wyh |
2024-12-19 |
| 67349 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
71 |
wyh |
2024-12-19 |
| 67350 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
98 |
h |
2024-12-19 |
| 67351 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
71 |
wyh |
2024-12-19 |
| 67352 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
159 |
h |
2024-12-19 |
| 67353 |
DOTA-多柔比星 DOTA-DOX |
101 |
h |
2024-12-19 |
| 67354 |
聚(HPMA)-c(RGDyK)-DOTA |
55 |
h |
2024-12-19 |
| 67355 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
75 |
h |
2024-12-19 |
| 67356 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
71 |
zyl |
2024-12-19 |
| 67357 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
105 |
h |
2024-12-19 |
| 67358 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
116 |
h |
2024-12-19 |
| 67359 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
151 |
h |
2024-12-19 |
| 67360 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
75 |
h |
2024-12-19 |
| 67361 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
96 |
h |
2024-12-19 |
| 67362 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
120 |
wyh |
2024-12-19 |
| 67363 |
cas:107348-47-0，2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate ADC抗体偶联药物 |
64 |
zyl |
2024-12-19 |
| 67364 |
SMCC-DM4 ， cas:1228105-52-9，ADC定制 |
61 |
wyh |
2024-12-19 |
| 67365 |
cas:1639939-40-4 Mal-Val-Ala-PAB-PNP |
70 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询